1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Premature Labor (Tocolysis) Global Clinical Trials Review, H2, 2015

Premature Labor (Tocolysis) Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Premature Labor (Tocolysis) Global Clinical Trials Review, H2, 2015" provides an overview of Premature Labor (Tocolysis) clinical trials scenario. This report provides top line data relating to the clinical trials on Premature Labor (Tocolysis). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Premature Labor (Tocolysis) Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Premature Labor (Tocolysis) to Women's Health Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Premature Labor (Tocolysis) to Women's Health Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Premature Labor (Tocolysis) Therapeutics Clinical Trials 28
Prominent Drugs 30
Latest Clinical Trials News on Premature Labor (Tocolysis) 31
Nov 04, 2015: ObsEva Presents Pharmacology Data Showing that OBE002, the First Orally Active Prostaglandin F2a Antagonist, is devoid of the side effects associated with NSAID treatment of Preterm Labor 31
Clinical Trial Profile Snapshots 32
Appendix 149
Abbreviations 149
Definitions 149
Research Methodology 150
Secondary Research 150
About GlobalData 151
Contact Us 151
Disclaimer 151
Source 151

List of Tables
Premature Labor (Tocolysis) Therapeutics, Global, Clinical Trials by Region, 2015* 6
Premature Labor (Tocolysis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Premature Labor (Tocolysis) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Premature Labor (Tocolysis) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Premature Labor (Tocolysis) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Premature Labor (Tocolysis) Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Premature Labor (Tocolysis) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13
Premature Labor (Tocolysis) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14
Proportion of Premature Labor (Tocolysis) to Women's Health Clinical Trials, G7 Countries (%), 2015* 15
Premature Labor (Tocolysis) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Premature Labor (Tocolysis) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Premature Labor (Tocolysis) to Women's Health Clinical Trials, E7 Countries (%), 2015* 18
Premature Labor (Tocolysis) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Premature Labor (Tocolysis) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Premature Labor (Tocolysis) Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Premature Labor (Tocolysis) Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Premature Labor (Tocolysis) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Premature Labor (Tocolysis) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Premature Labor (Tocolysis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25
Premature Labor (Tocolysis) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 26
Premature Labor (Tocolysis) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27
Premature Labor (Tocolysis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Premature Labor (Tocolysis) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

List of Figures
Premature Labor (Tocolysis) Therapeutics, Global, Clinical Trials by Region (%), 2015* 6
Premature Labor (Tocolysis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Premature Labor (Tocolysis) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Premature Labor (Tocolysis) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Premature Labor (Tocolysis) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Premature Labor (Tocolysis) Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Premature Labor (Tocolysis) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13
Premature Labor (Tocolysis) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14
Proportion of Premature Labor (Tocolysis) to Women's Health Clinical Trials, G7 Countries (%), 2015* 15
Premature Labor (Tocolysis) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Premature Labor (Tocolysis) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Premature Labor (Tocolysis) to Women's Health Clinical Trials, E7 Countries (%), 2015* 18
Premature Labor (Tocolysis) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Premature Labor (Tocolysis) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Premature Labor (Tocolysis) Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Premature Labor (Tocolysis) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Premature Labor (Tocolysis) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Premature Labor (Tocolysis) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Premature Labor (Tocolysis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25
Premature Labor (Tocolysis) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 26
Premature Labor (Tocolysis) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27
Premature Labor (Tocolysis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28
Premature Labor (Tocolysis) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
GlobalData Methodology 150

Companies mentioned
GlaxoSmithKline Plc
ZonMw
Jaguar Holding Company II
AMAG Pharmaceuticals, Inc.
Obstetrix Medical Group
ObsEva SA
Nutrinia Ltd.
Juniper Pharmaceuticals, Inc.
Ferring International Center S.A.
Christiana Care Health System

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Global and Chinese Progesterone Industry, 2017 Market Research Report

Global and Chinese Progesterone Industry, 2017 Market Research Report

  • $ 3000
  • Industry report
  • February 2017
  • by Prof Research

The ’Global and Chinese Progesterone Industry, 2012-2022 Market Research Report’ is a professional and in-depth study on the current state of the global Progesterone industry with a focus on the Chinese ...

Global and Chinese Norethindrone (CAS 68-22-4) Industry, 2017 Market Research Report

Global and Chinese Norethindrone (CAS 68-22-4) Industry, 2017 Market Research Report

  • $ 3000
  • Industry report
  • February 2017
  • by Prof Research

The 'Global and Chinese Norethindrone Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Norethindrone industry with a focus on the Chinese ...

Global and Chinese Testosterone Undecanoate (CAS 5949-44-0) Industry, 2017 Market Research Report

Global and Chinese Testosterone Undecanoate (CAS 5949-44-0) Industry, 2017 Market Research Report

  • $ 3000
  • Industry report
  • February 2017
  • by Prof Research

The 'Global and Chinese Testosterone Undecanoate Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Testosterone Undecanoate industry with ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market in China

  • February 2017
    8 pages
  • Therapy  

    Contraceptive  

  • China  

View report >

Hormone and Therapy Market in Pakistan and the US

  • February 2017
    7 pages
  • Hormone  

    Therapy  

    Diabetes  

  • Pakistan  

    United States  

View report >

Insulin Market and Diabetes Statistics in the US

  • February 2017
    8 pages
  • Insulin  

    Antidiabetics  

    Diabetes  

  • United States  

View report >

Related Market Segments :

Hormone
Dietary Supplement

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.